Publications by authors named "Xi Ming Tang"

12Publications

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.

Authors:
Carl M Gay Yanhong Zhou J Jack Lee Xi Ming Tang Wei Lu Ignacio I Wistuba Renata Ferrarotto Don L Gibbons Bonnie S Glisson Merrill S Kies George R Simon John V Heymach Anne S Tsao

Oncologist 2020 Oct 19;25(10):e1457-e1463. Epub 2020 Jul 19.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
October 2020

Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.

Authors:
Yanyan Lou Chad V Pecot Hai T Tran Vikki J DeVito Xi Ming Tang John V Heymach Raja Luthra Ignacio I Wistuba Zhuang Zuo Anne S Tsao

Clin Lung Cancer 2016 Mar 17;17(2):e5-11. Epub 2015 Nov 17.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
March 2016

Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.

Authors:
Anne S Tsao Suyu Liu J Jack Lee Christine Alden George Blumenschein Roy Herbst Suzanne E Davis Edward Kim Scott Lippman David Stewart Xi Ming Tang Ignacio Wistuba Waun Ki Hong

J Thorac Oncol 2012 Nov;7(11):1645-52

Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
November 2012

MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.

Authors:
Deeksha Vishwamitra Yong Li Desiree Wilson Roxsan Manshouri Choladda V Curry Bin Shi Xi Ming Tang Andrea M Sheehan Ignacio I Wistuba Ping Shi Hesham M Amin

Am J Pathol 2012 May 10;180(5):1772-80. Epub 2012 Mar 10.

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
May 2012

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.

Authors:
Faye M Johnson B Nebiyou Bekele Lei Feng Ignacio Wistuba Xi Ming Tang Hai T Tran Jeremy J Erasmus Li-Ling Hwang Naoko Takebe George R Blumenschein Scott M Lippman David J Stewart

J Clin Oncol 2010 Oct 20;28(30):4609-15. Epub 2010 Sep 20.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article and Find Full Text PDF
October 2010

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Authors:
Anne S Tsao Diane Liu Jack Martin Xi-ming Tang J Jack Lee Adel K El-Naggar Ignacio Wistuba Kirk S Culotta Li Mao Ann Gillenwater Yuko M Sagesaka Waun K Hong Vassiliki Papadimitrakopoulou

Cancer Prev Res (Phila) 2009 Nov;2(11):931-41

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
November 2009

Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.

Authors:
Wenjuan Wu Michael S O'Reilly Robert R Langley Rachel Z Tsan Cheryl H Baker Neby Bekele Xi Ming Tang Amir Onn Isaiah J Fidler Roy S Herbst

Mol Cancer Ther 2007 Oct 3;6(10):2652-63. Epub 2007 Oct 3.

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA.

View Article and Find Full Text PDF
October 2007

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

Authors:
Anne S Tsao Xi Ming Tang Bradley Sabloff Lianchun Xiao Hisayuki Shigematsu Jack Roth Margaret Spitz Waun Ki Hong Adi Gazdar Ignacio Wistuba

J Thorac Oncol 2006 Mar;1(3):231-9

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article and Find Full Text PDF
March 2006

Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.

Authors:
Frank A Sinicrope Robert C Penington Xi Ming Tang

Clin Cancer Res 2004 Dec;10(24):8284-92

Divisions of Oncology, Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. sinicrope.frank2mayo.edu

View Article and Find Full Text PDF
December 2004

Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.

Authors:
Yunjie Sun Xi Ming Tang Elizabeth Half M Tien Kuo Frank A Sinicrope

Cancer Res 2002 Nov;62(21):6323-8

Department of Gastrointestinal Medicine and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

View Article and Find Full Text PDF
November 2002

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

Authors:
Elizabeth Half Xi Ming Tang Karin Gwyn Aysegul Sahin Kyle Wathen Frank A Sinicrope

Cancer Res 2002 Mar;62(6):1676-81

Department of Gastrointestinal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
March 2002

In situ hybridization assay of androgen receptor gene in hepatocarcinogenesis.

Authors:
Guo-Qiang Zhao Ling Xue Hong-Yu Xu Xi-Ming Tang Rui-De Hu Jun Dong

World J Gastroenterol 1998 Dec;4(6):503-505

View Article and Find Full Text PDF
December 1998